Birmaher, B., Quintana, H., & Greenhill, L. L. (1988). Methylphenidate treatment of hyperactive autistic children. Journal of the American Academy Child and Adolescent Psychiatry, 27, 248-251.
2.
Campbell, M., Adams, P., Perry, R., Speneer, R. K., & Overall, J. E. (1985). Tardive and withdrawal dyskinesia in children: A prospective study. Psychopharmacological Bulletin, 24, 251-255.
3.
Dahlin, M., Elfving, A., Ungerstedt, U., & Amark, P. (2005). The ketogenic diet influences the levels of excitatory and inhibitory amino acids in the CFS in children with refractory epilepsy. Epilepsy Research, 13.
4.
Deutsch, S. I., & Campbell, M. (1984). Status of cholinesterase activities in blood in neuropsychiatric disorders. Neurochemical Research, 9, 863-869.
5.
Deutsch, S. I., Milstoc, M., Platovsky, G., Wolsky, B. B., Perry, R., & Green, W. H. (1987). Cholinesterase activities in blood in infantile autism. Biol Psychiatry, 22, 234-236.
6.
Grasshoff, C., Gillessen, T., Wagner, E., Thiermann, H., & Szinicz, L. (2005). Ketamine reduces cholinergic modulated GABA release from rat striatal slices. Toxicology Letters, 28, 156.
7.
Jaselskis, C. A., Cook, E. H., Fleteher, K. E., & Leventhal, B. L.Clonidine treatment of hyperactive and impulsive children with autistic disorder. Journal of Clinical Psychopharmocology, 5, 322-327.
8.
Murphy, P., Likhodii, S. S., Hatamian, M., McIntyre, W., & Burnham, W. (2005). Effect of the ketogenic diet on the activity level of Wistar rats. Pediatric Research, 57(3), 353-357.
9.
Palmen, S. J., & Van Egeland, H. (2004). Review on structural neuroimaging findings in autism. Journal of Neural Transmission, 111, 903-920.
10.
Perry, R., Campbell, M., Adams, P., Lyneh, N., & Speneer, E. K. (1959). Long-term efficacy of haloperidol in children: Continuous versus discontinuous drug administration. Journal of the American Academy Child and Adolescent Psychiatry, 25, 57-92.
